Results 21 to 30 of about 39,387 (293)

Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundThe aim of this study was to analyze the benefits and safety associated with the combination therapy of clopidogrel and aspirin among minor stroke or transient ischemic attack patients treated within 12 hours.
Zixiao Li   +16 more
doaj   +1 more source

Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) [PDF]

open access: yes, 2016
Introduction: Atrial fibrillation is an independent risk factor of thromboembolism. Women with atrial fibrillation are at a higher overall risk for stroke compared to men with atrial fibrillation. The aim of this study was to evaluate for sex differences
Abdul-Rahim, Azmil   +72 more
core   +1 more source

Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event [PDF]

open access: yes, 2010
Objective To compare gender-related lifestyle changes and risk factor management after hospitalisation for a coronary event or revascularisation intervention in Europe.
C. Prugger   +8 more
core   +2 more sources

Clinical Outcomes of Intracerebral Hemorrhage in Hemodialysis Patients [PDF]

open access: yes, 2014
BackgroundChronic renal failure (CRF) is associated with a high incidence of stroke. In particular, the mortality rate for intracerebral hemorrhage (ICH) patients with hemodialysis (HD) due to advanced stage CRF is high, and the annual number of such ...
Aoki Kazuyasu   +8 more
core   +1 more source

Drugs for spontaneous coronary dissection: a few untrusted options

open access: yesFrontiers in Cardiovascular Medicine, 2023
Spontaneous coronary artery dissection (SCAD) is a rare cause of acute coronary syndrome that is often overlooked, misdiagnosed, and maltreated. Medical treatment poses a significant challenge because of the lack of randomized studies to guide treatment.
Ivan Ilic   +12 more
doaj   +1 more source

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388) [PDF]

open access: yes, 2015
RATIONALE: The risk of recurrence following a stroke or transient ischemic attack is high, especially immediately after the event. HYPOTHESIS: Because two antiplatelet agents are superior to one in patients with non-cardioembolic events, more ...
Bath, Philip M.W.   +13 more
core   +1 more source

The Use of Prasugrel and Ticagrelor in Pipeline Flow Diversion [PDF]

open access: yes, 2018
Background: Despite the routine clopidogrel/aspirin anti-platelet therapy, complications like thromboembolism, continue to be encountered with PED.
Atallah, MD, Elias   +9 more
core   +2 more sources

Disclosure and adverse effects of complementary and alternative medicine used by hospitalized patients in the North East of England [PDF]

open access: yes, 2012
Objectives: This study aimed to investigate the prevalence, disclosure and adverse effects of complementary and alternative medicine (CAM) use in hospitalised patients, and to explore the associations between patients’ perceived side-effects and relevant
Baqir, wasim   +3 more
core   +2 more sources

Return to the workforce following first hospitalization for heart failure: a Danish nationwide cohort study [PDF]

open access: yes, 2016
Background: Return to work is important financially, as a marker of functional status and for self-esteem in patients developing chronic illness. We examined return to work after first heart failure (HF) hospitalization.
Fosbøl, Emil L.   +13 more
core   +2 more sources

COMPARISON OF THE ORIGINAL (PLAVIx) AND GENERIC (CLAPITAx) CLOPIDOGREL ON PLATELET  AGGREGATION: ObSERVATIONAL STUDY

open access: yesРоссийский кардиологический журнал, 2018
Aim. To compare antiplatelet activeness of the original clopidogrel and its generic, and to evaluate the routine practice of antiplatelet drugs intake by clinically stable patients aiming prevention of atherothrombosis.Material and methods.
A. S. Skotnikov   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy